Iterum Therapeutics (ITRM) Stock Chart & Stock Price History → Write this ticker symbol down… (From StocksToTrade) (Ad) Free ITRM Stock Alerts $1.38 -0.03 (-2.13%) (As of 06/7/2024 08:52 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Iterum Therapeutics Stock Price Performance5 Day Performance-7.38%1 Month Performance-14.29%3 Month Performance-10.97%6 Month Performance-20.92%Year-To-Date Performance-29.95%1 Year Performance+23.21% Receive ITRM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Iterum Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad HedgeyeNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analysis meets hedge fund-level market foresight!TRY "INVESTING IDEAS" TODAY ITRM Stock Chart for Monday, June, 10, 2024 ITRM Chart by TradingView Iterum Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/07/2024$1.41$1.38-2.13%$1.43$1.32182,867 shs$22.85 million06/06/2024$1.48$1.41-4.73%$1.47$1.39112,665 shs$23.35 million06/05/2024$1.49$1.48-0.67%$1.50$1.4082,902 shs$24.51 million06/04/2024$1.43$1.49+4.20%$1.51$1.38133,942 shs$24.67 million06/03/2024$1.50$1.43-4.67%$1.59$1.38182,157 shs$23.68 million05/31/2024$1.29$1.50+16.28%$1.50$1.34329,404 shs$24.84 million Get the Latest News and Ratings for ITRM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Iterum Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/30/2024$1.29$1.29$1.31$1.2566,977 shs$21.36 million05/29/2024$1.32$1.29-2.27%$1.35$1.2681,184 shs$21.36 million05/28/2024$1.35$1.32-2.22%$1.38$1.23217,117 shs$21.86 million05/27/2024$1.35$1.35$1.44$1.3475,400 shs$22.36 million05/24/2024$1.39$1.37-1.44%$1.44$1.3475,400 shs$22.69 million05/23/2024$1.42$1.39-2.11%$1.47$1.35101,475 shs$23.02 million05/22/2024$1.41$1.42+0.71%$1.44$1.4157,787 shs$23.52 million05/21/2024$1.45$1.41-2.76%$1.45$1.4045,132 shs$23.35 million05/20/2024$1.41$1.45+2.84%$1.49$1.37122,515 shs$24.01 million05/17/2024$1.48$1.41-4.73%$1.53$1.36177,549 shs$23.35 million05/16/2024$1.49$1.48-0.67%$1.53$1.4663,473 shs$24.50 million05/15/2024$1.50$1.49-0.67%$1.55$1.4753,337 shs$24.67 million05/14/2024$1.52$1.50-1.32%$1.59$1.47106,316 shs$24.84 million05/13/2024$1.55$1.52-1.94%$1.66$1.45195,354 shs$25.17 million05/10/2024$1.61$1.55-3.73%$1.60$1.50110,005 shs$25.67 million05/09/2024$1.60$1.61+0.63%$1.62$1.5657,311 shs$26.66 million05/08/2024$1.55$1.60+3.23%$1.64$1.5620,128 shs$26.50 million05/07/2024$1.59$1.55-2.52%$1.65$1.55128,192 shs$25.67 million05/06/2024$1.55$1.59+2.58%$1.65$1.5494,140 shs$26.33 million05/03/2024$1.58$1.55-1.90%$1.63$1.5246,917 shs$25.67 million05/02/2024$1.59$1.58-0.63%$1.62$1.54233,234 shs$26.17 million05/01/2024$1.53$1.59+3.92%$1.62$1.45237,734 shs$26.32 million04/30/2024$1.54$1.53-0.65%$1.64$1.50157,708 shs$25.14 million04/29/2024$1.67$1.54-7.78%$1.75$1.48510,757 shs$25.30 million04/26/2024$1.57$1.69+7.64%$1.72$1.52106,274 shs$27.77 million04/25/2024$1.55$1.57+1.29%$1.57$1.5050,845 shs$25.80 million04/24/2024$1.58$1.55-1.90%$1.60$1.5035,939 shs$25.47 million04/23/2024$1.55$1.58+1.94%$1.60$1.5536,278 shs$25.96 million04/22/2024$1.43$1.55+8.39%$1.60$1.46197,643 shs$25.46 million04/19/2024$1.43$1.43$1.51$1.4259,817 shs$23.50 million04/18/2024$1.44$1.43-0.69%$1.46$1.4356,731 shs$23.50 million04/17/2024$1.45$1.44-0.69%$1.50$1.4275,335 shs$23.66 million04/16/2024$1.54$1.45-5.84%$1.55$1.45168,662 shs$23.82 million04/15/2024$1.58$1.54-2.53%$1.63$1.5098,692 shs$25.30 millionIt's time to ween off Chinese lithium! (Ad)As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promising companies to be watching closelyLearn how this American company is leading the lithium-ion revolution04/12/2024$1.62$1.58-2.47%$1.65$1.5882,978 shs$25.96 million04/11/2024$1.64$1.62-1.22%$1.70$1.6042,966 shs$26.62 million04/10/2024$1.67$1.64-1.80%$1.74$1.61136,157 shs$26.95 million04/09/2024$1.70$1.67-1.76%$1.76$1.65119,638 shs$27.44 million04/08/2024$1.76$1.70-3.41%$1.82$1.65187,688 shs$27.93 million04/05/2024$1.87$1.76-5.88%$1.85$1.72215,910 shs$28.92 million04/04/2024$1.55$1.87+20.65%$1.93$1.59749,402 shs$30.72 million04/03/2024$1.60$1.55-3.13%$1.60$1.5388,134 shs$20.82 million04/02/2024$1.64$1.60-2.44%$1.65$1.55131,141 shs$21.50 million04/01/2024$1.54$1.64+6.49%$1.66$1.55158,512 shs$22.04 million03/29/2024$1.54$1.54$1.67$1.49228,461 shs$20.70 million03/28/2024$1.59$1.54-3.14%$1.67$1.49225,397 shs$20.70 million03/27/2024$1.56$1.59+1.92%$1.61$1.54144,483 shs$21.37 million03/26/2024$1.55$1.56+0.65%$1.58$1.5275,185 shs$20.97 million03/25/2024$1.60$1.55-3.13%$1.63$1.5499,254 shs$20.83 million03/22/2024$1.58$1.60+1.27%$1.65$1.54115,222 shs$21.50 million03/21/2024$1.58$1.58$1.61$1.5578,600 shs$21.24 million03/20/2024$1.65$1.58-4.24%$1.67$1.57226,902 shs$21.24 million03/19/2024$1.63$1.65+1.23%$1.67$1.62175,977 shs$22.18 million03/18/2024$1.46$1.63+11.64%$1.66$1.55266,759 shs$21.91 million03/15/2024$1.45$1.46+0.69%$1.53$1.4179,489 shs$19.62 million03/14/2024$1.52$1.45-4.61%$1.50$1.4351,599 shs$19.48 million03/13/2024$1.67$1.52-8.98%$1.68$1.43246,753 shs$20.42 million03/12/2024$1.62$1.67+3.09%$1.69$1.56135,877 shs$22.45 million03/11/2024$1.55$1.62+4.52%$1.69$1.54299,775 shs$21.77 million03/08/2024$1.51$1.55+2.65%$1.59$1.51164,650 shs$20.83 million Related Companies: Nabriva Therapeutics Stock Price Chart Clearside Biomedical Stock Price Chart Verastem Stock Price Chart InflaRx Stock Price Chart ProPhase Labs Stock Price Chart Eton Pharmaceuticals Stock Price Chart SCYNEXIS Stock Price Chart Assertio Stock Price Chart Connect Biopharma Stock Price Chart Hillstream BioPharma Stock Price Chart Receive ITRM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Iterum Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ITRM) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredRSVP: Charles Payne’s Cash Flow WorkshopDid you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...Unstoppable Prosperity | SponsoredNvidia needs this one obscure firm In my new investigation, I detail why this is the single most important factor in the future of AI. I expla...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Iterum Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Iterum Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.